DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.54, $0.37 better than the analyst estimate of $0.17. Revenue for the quarter came in at $338 million versus the consensus estimate of $307.52 million.

GUIDANCE:

DexCom sees FY2019 revenue of $1.175-1.225 billion, versus the consensus of $1.28 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.